Behjati Farkhondeh, Ghasemi Firouzabadi Saghar, Sajedi Firoozeh, Kahrizi Kimia, Najafi Mostafa, Ebrahimizade Ghasemlou Behruz, Shafeghati Yousef, Behnia Fatemeh, Mohammadi Arya Ali Reza, Karimi Hossein, Hadipour Fatemeh, Hadipour Zahra, Jamali Peyman, Kariminejad Roxana, Darvish Hossein, Bahman Ideh, Bagherizadeh Eiman, Najmabadi Hossein, Vameghi Roshanak
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, IR Iran.
Pediatric Neurorehabilitation Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, IR Iran.
Iran Red Crescent Med J. 2013 Oct;15(10):e8221. doi: 10.5812/ircmj.8221. Epub 2013 Oct 5.
Mental retardation/Developmental delay (MR/DD) is present in 1 - 3% of the general population (1, 2). MR is defined as a significant impairment of both cognitive (IQ < 70) and social adaptive functions, with onset before 18 years of age.
The purpose was to determine the results of subtelomeric screening by the Multiplex Ligation Dependent Probe Amplification (MLPA) Technique in 100 selected patients with idiopathic mental retardation (IMR) in Iran.
A number of 100 patients with IMR, normal karyotypes and negative fragile-X and metabolic tests were screened for subtelomeric abnormalities using MLPA technique.
Nine of 100 patients showed subtelomeric abnormalities with at least one of the two MLPA kits. Deletion in a single region was found in 3 patients, and in two different subtelomeric regions in 1 patient. Duplication was only single and was present in 2 patients. Three patients were found to have both a deletion and duplication.MLPA testing in the parental samples of 7 patients which was accessible showed that 4 patients were de novo, 2 patients had inherited from a clinically normal mother, and one had inherited from a clinically normal father. Screening with the two MLPA kits (SALSA P036 and SALSA P070) proved abnormality in only five of the 9 patients.
So, the prevalence rate of abnormal subtelomeres using MLPA technique in patients with idiopathic MR in our study was 5 - 9%, the higher limit referring to the positive results of one of the two MLPA kits, and the lower limit representing the results of positive double-checking with the two MLPA kits.
智力迟钝/发育迟缓(MR/DD)在普通人群中的发生率为1% - 3%(参考文献1, 2)。智力迟钝被定义为认知能力(智商<70)和社会适应功能均有显著损害,且发病于18岁之前。
本研究旨在确定运用多重连接依赖探针扩增(MLPA)技术对伊朗100例特发性智力迟钝(IMR)患者进行亚端粒筛查的结果。
运用MLPA技术对100例IMR患者进行亚端粒异常筛查,这些患者核型正常,脆性X检测和代谢检测均为阴性。
100例患者中有9例至少在两种MLPA试剂盒中的一种检测中显示亚端粒异常。3例患者在单个区域发现缺失,1例患者在两个不同的亚端粒区域发现缺失。重复仅出现1次,见于2例患者。3例患者同时存在缺失和重复。在可获取亲代样本的7例患者中进行MLPA检测,结果显示4例为新发突变,2例从临床正常的母亲遗传而来,1例从临床正常的父亲遗传而来。使用两种MLPA试剂盒(SALSA P036和SALSA P070)进行筛查,仅9例患者中的5例检测出异常。
因此,在我们的研究中,运用MLPA技术检测特发性智力迟钝患者亚端粒异常的患病率为5% - 9%,上限指两种MLPA试剂盒中一种检测的阳性结果,下限代表两种MLPA试剂盒双重检测的阳性结果。